S4 E2 The Oncology Journal Club: Chrono-Oncology, Genomic Therapy Matching + iCCA

Send us Fan MailIn this episode of The Oncology Journal Club, the team weigh promising trial signals against the level of evidence needed to change clinical practice. From perioperative cholangiocarcinoma to molecular matching and chrono-oncology, the focus stays on a key question: what meaningfully improves outcomes for patients?What’s covered NeoGOLP trial in high-risk resectable iCCA: improved event-free survival; overall survival still immature  MoST programme: molecular matching and survival associations when therapies align with biomarkers  Genomic therapy matching in clinical decision-making  Chrono-oncology: does treatment timing influence outcomes?  CHOPIN phase II uveal melanoma trial: combination therapy signals and feasibility  ASCO living guideline updates across lung, gastro-oesophageal and thyroid cancers The Oncology Journal Club Podcast hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson, and proudly produced by The Oncology NetworkVisit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information.